Niagen Bioscience Inc (NAGE)

$NAGE https://x.com/niagenbio/status/1996712543369548101?s=42

Potential Swing Watchlist $BKKT $ORIC $UAMY $NAGE $TLRY

$NAGE https://www.niagenplus.com/blogs/blog/behind-the-science-an-interview-with-dr-rachele-pojednic-on-niagen-iv-therapy-at-restore

$NAGE https://x.com/glossyco/status/1989060819838005576?s=12

$NAGE - Platelet mitochondrial complex I and IV activities are not reliable stratification biomarkers in Parkinson's disease Dr. Tzoulis paper Epub 2025 Aug 14. "Plain language summary" "Dysfunction of the mitochondria, the cells’ powerhouses, plays an important role in Parkinson's disease (PD). However, recent findings suggest that this dysfunction may be more pronounced in some persons with PD (PwPs) than others. Analyses in tissue samples from autopsy have shown that approximately 20–30% of PwPs harbor widespread mitochondrial dysfunction in their brain. These individuals may be more susceptible to the effects of mitochondria-targeting treatments. " "more pronounced" may point to NOPARK findings that may very by subtype, but still be present in others? TBD by much smarter minds that me. https://pubmed.ncbi.nlm.nih.gov/40808415/

$NAGE - Nicotinamide riboside enhances the efficacy of gemcitabine and suppresses PDAC premalignant lesions via SIRT3 activation Mouse study "Based on these findings across diverse malignancies, we speculate that NR may also be beneficial in pancreatic cancer" https://www.sciencedirect.com/science/article/abs/pii/S0006295225008500

$NAGE https://www.instagram.com/p/DRzsriCkSza/?igsh=MXBiMmp0a2d6cDd0aw==

$NAGE maybe we can get acquired by Sam Altman’s longevity play?

$NAGE $CAPR today. Nice move. When Parkinson’s study results released this could be a good indication of market response.

B2i Digital is pleased to announce Niagen Bioscience, Inc. (Nasdaq: $NAGE ) is participating in the 14th Annual ROTH Deer Valley Event hosted by ROTH Capital Partners, taking place December 10–13, 2025, at the Montage Deer Valley in Park City, Utah. Niagen Bioscience, Inc. (NASDAQ:NAGE) is the world’s leading NAD+ company on a mission to extend healthspan. Its team of world-renowned scientists works with independent investigators from esteemed universities and research institutions worldwide to uncover the full potential of NAD+, a vital coenzyme in every human cell that declines with age and daily stressors and contributes to age-related changes in health and vitality. At the heart of its clinically proven portfolio is Niagen® (patented nicotinamide riboside, or NR), the most efficient, well-researched and legal NAD+ booster available, powering Tru Niagen®, the number one NAD+ boosting oral supplement in the United States† (www.truniagen.com), and Niagen Plus™, a line of pharmaceutical-grade IV and injectable Niagen products (www.niagenplus.com). The 14th Annual ROTH Deer Valley Event is a B2i Digital Featured Conference. See more details at: https://b2idigital.com/14th-annual-roth-deer-valley-event This invitation-only event connects about 50 growth-company executives with institutional investors in an intimate mountain setting. Conference features include: • 40-minute one-on-one and group management-investor meetings • Economics discussion with Michael Darda, Chief Economist & Market Strategist at ROTH • Group dinners at Daly’s Pub and Spur Bar & Grill in Park City • Optional skiing, yoga and spin classes, and après ski gatherings • Welcome event on December 10th with cocktails and carving stations Registration is required and subject to approval by ROTH. For registration details, visit: https://www.meetmax.com/sched/event_123737/conference_home.html We appreciate the exceptional ROTH leadership and investment banking team for making this premier event possible: Byron Roth, Ted Roth, Sagar Sheth, Aaron Gurewitz, Isabel Mattson-Pain, Gordon Roth, Nazan Akdeniz, Alexander Montano, Marc Lewis, James Antonopoulos, Jesse Pichel, Michael Guzman, Robert Stephenson, Paul Zaffaroni, Salomon Kamalodine, Al Longfield, Benjamin Bowen, and Joe Tonnos. ROTH is a relationship-driven investment bank headquartered in Newport Beach, CA, focused on serving growth companies and their investors. Their full-service platform provides capital raising, high-impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory, and corporate access. For more information on ROTH, please visit: www.roth.com. We look forward to supporting this unique gathering of growth company leaders and investors in Park City, Utah. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security.